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Abstract
Background: Pseudomonas aeruginosa is considered as a leading cause of nosocomial infections. Burn and wound infections are mainly caused by multidrug-resistant P. aeruginosa isolates. Drug resistance frequently occurs among nosocomial isolates and can usually resist a myriad of antibiotics such as novel β-lactam antibiotics. Detection of multidrug-resistant isolates could assist better drug administration.
Objectives: The aim of this study was to detect Extended Spectrum Beta-Lactamases (ESBL) positive wound isolates and the genes encoding 
blaVEB-1 ESBL among wound isolates of P. aeruginosa.Materials and Methods: A total of 89 wound isolates of P. aeruginosa were collected from patients (47% (n = 42) were male and 53% (n = 47) were female) at six Iranian hospitals between years 2009 and 2011. Antibiotic susceptibility and phenotypic ESBL production tests were conducted. The combined disk was used to determine ESBLs production. The blaVEB-1 gene was detected with the polymerase chain reaction (PCR).
Results: The majority of the wound isolates were resistant to augmentin (90%, n = 80) and cefpodoxime (87.6%, n = 78). However, the majority was susceptible to imipenem and meropenem. Fifty-eight (42%) wound isolates were ESBL positive. The antibiotic resistance amongst ESBL positive isolates was relatively higher than ESBL negative isolates. Twenty-three (40%) ESBL-positive isolates amplified the 
blaVEB-1 gene.Conclusions: More than behalf of the wound isolates were ESBL positive, and the presence of blaVEB-1 was determined in less than half of these isolates. Fortunately, resistance to imipenem and meropenem was low.
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1. Background
Pseudomonas aeruginosa (P. aeruginosa) isolates are known as potential opportunistic organisms, frequently involved in infections of immune suppressed or hospi-talized patients, and also cause outbreaks of hospital-ac-quired infections. These strains are inherently resistant to an extended spectrum of antibiotics, including novel 
β-lactam agents, and thereby can culminate in high mor-bidity and mortality rates (1). Useful antibiotics include extended spectrum beta-lactamases (ESBL) and carbapen-ems, though multidrug-resistant isolates have emerged in hospital settings (2). Of several primary antibiotic re-sistant mechanisms, the down-regulation of membrane porins (OprD), in addition to increase in the expression of multidrug efflux pumps (MexAB-OprM) help intrin-
sic drug resistance (3). Novel beta-lactamases, including AmpC, extended spectrum beta-lactamases (ESBLs) and likewise several metallo beta-lactamases (MBLs) have emerged around the world as genetic encoding reser-voirs responsible for the antimicrobial resistance among different gram-negative isolates (4). The ESBL enzymes are encoded by plasmids and integrons and were first re-ported in isolates of Klebsiella pneumonia, in Germany (5). In P. aeruginosa several classes of enzymes including class A ESBLs, which are comprised of blaPER-1 and blaVEB-1, and GES/IBC and BEL types have been identified; these were initially reported in Turkey, south Asia and France. These six types of ESBLs at the genetic level have a low similar-ity, but they are identical regarding hydrolysis profiles 
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(6). The ESBL enzymes have been demonstrated to be the derivatives of TEM- and SHV-lactamases, with minor ge-netic mutation in the active site (7). These enzymes have shown resistance to extended spectrum cephalosporins. Furthermore, there have reports of non-TEM and non-SHV ESBLs in several areas (8, 9). Among several acquired beta-lactamase enzymes, the blaVEB-1 has the greatest clinical importance as it causes resistance to oxyimino beta-lactams (10). On the other hand, resistance to car-bapenems in P. aeruginosa, alongside K. pneumoniae and 
Acinetobacter baumannii, is of high concern (11). Implica-tion for health policy/practice/research/medical educa-tion: P. aeruginosa is a nosocomial pathogen and likewise the increasing rate of antibiotic resistance has become a great concern. Among several mechanisms of drug resis-tance, there are ESBL enzymes that confer the resistance to a broad range of antibiotics in beta lactam family. De-tection of ESBLs and their importance and prevalence can help for better follow up of this pathogen.
2. ObjectivesThe aim of this study was to detect the production of ES-BLs and prevalence of blaVEB-1 gene among wound isolates of P. aeruginosa. 
3. Materials and MethodsA total of 89 clinical isolates of P. aeruginosa were col-lected from wound samples in several hospitals between years 2009 and 2011. The isolates were identified by gram staining, catalase and oxidase tests, motility on Sulfide in-dole motility (SIM) medium, indole production, H2S pro-duction, characteristics on the triple sugar iron (TSI) agar culture medium, methyl red (MR) test, voges proskauer (VP) medium, Simon citrate agar, oxidative/fermentative (OF) test, urea broth, growth on MacConkey agar and also 
on cetrimide agar media. The isolates were then subse-quently stored at -70°C for future studies.The antibiotic susceptibility test of the isolates was per-formed on the basis of Clinical and Laboratory Standards Institute (CLSI) guidelines. The antibiotic disks used in the present study have been depicted in Table 1.Production of ESBLs by P. aeruginosa isolates was deter-mined using the usual combined disk test. In the com-bined disk test, both ceftazidime and cefotaxime disks in the presence or absence of clavulanic acid were used on the muller hinton agar (MHA) culture Plates. A positive test was indicated when the difference in the diameter in the absence of clavulanic acid was equal or more than 5 mm when compared to the diameter in the presence of clavulanic acid.Following the suspension of a colony of each bacterial isolate in 10 mL of Luria Bertani (LB) broth medium, and then incubation overnight at 37°C, the tubes were cen-trifuged for 10 minutes at 4000 rpm and the obtained precipitate was re-suspended in sterile H2O for DNA ex-traction. Furthermore, for DNA isolation, the boiling and DNA Extraction kit (DIAtom DNA Prep 100) methods were used.The PCR was performed for the detection of the ESBL encoding gene of blaVEB-1 by the employment of specific primers, as shown in Table 2.The reaction mixture for these genes included: 10X PCR buffer = 2.5 µL, dNTP (10 Mm) = 0.75 µL, MgCl2 (50 mM) = 1.5 µL, forward primer (100 µM) = 2.5 µL, reverse primer (100 µM) = 2.5 µL, template (DNA) = 1 µL, Taq DNA poly-merase (5 U/µL) = 0.2 µL, and nuclease-free H2O = 14.05 µL.
3.1. Statistical AnalysisThe analysis of data was performed with application of the Student’s t-test.
Table 1. Three Families of Antibiotics Used in This Study
Antibiotic Family Disks and Concentrations
Beta-lactams, µg Aztreonam (30), piperacillin (100), carbenicillin (100), meropenem (10), netilmicin (30), ticarcillin (75), piperacillin-tazobactam (110), cefoperazone (75), augmentin (30), cefotaxime (30), imipenem (10), cefpodoxime (10), ceftriaxone (30), ceftazidime (30) and cefepime (30)
Fluoroquinolones, µg Ofloxacin (5), ciprofloxacin (5), levofloxacin (5)
Aminoglycosides, µg Amikacin (30), tobramycin (10), gentamicin (120)
Table 2. The Primers Used in This Study
Primer Sequence 5 to 3 Product Size Reference
blaVEB-1 699 (12)F: AATGGCAATCAGCGCTTC
R: GCGCGACTGTGATGTATA
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4. ResultsThe wound isolates of P. aeruginosa were collected from six hospitals of Tehran (Shariati, burn center), Shiraz (Namazi), Ilam (Imam Khomeini), Kerman (Bahonar), Kermanshah (Imam Khomeini), and Ahvaz (Imam) city. These isolates were identified with conventional bio-chemical tests.The majority of the wound isolates were susceptible to imipenem and meropenem antibiotics. However, most were resistant to augmentin disk and cefpodoxime. The difference between ESBL- and non-ESBL-producing iso-lates regarding resistance has been classified in Table 3.Fifty-eight (56.1%) of the wound P. aeruginosa isolates were ESBL positive, among which 40% (n = 26) were iso-lated from males and 60% (n = 32) from females. The an-tibiotic resistance pattern was higher in these isolates relative to ESBL-negative isolates, although no significant difference was observed (P ≤ 0.05), as shown in Table 3. The prevalence of ESBLs in each hospital were as follows; Tehran (n = 11), Shiraz (n = 6), Ilam (n = 8), Kerman (n = 11), Kermanshah (n = 8) and Ahvaz (n = 6).
Table 3. The Antibiotic Susceptibility Test Pattern for the Extended Spectrum B-Lactamases Positive and Negative Wound 
Pseudomonas aeruginosa Isolates
Disks/Isolates ESBL-Positive 
(Resistance %), n = 35
ESBL-Negative 
(Resistance %), n = 54
Augmentin 100 92
Cefepime 96 68
Ceftazidime 89 66
Cefpodoxime 86 54
Carbenicillin 87 63
Ceftriaxone 99 63
Piperacillin 88 46
Aztreonam 86 62
Cefoperazone 89 46
Cefotaxime 98 67
Ticarcillin 68 56
Imipenem 22 17
Meropenem 23 18
Ciprofloxacin 89 65
Levofloxacin 78 44
Ofloxacin 76 55
Netilmicin 63 45
Amikacin 82 42
Gentamicin 68 43
Tobramycin 68 46
Piperacillin 56 37
Table 4. Association Between Third-Generation Cephalosporins Resistance and Extended Spectrum Beta-Lactamase Genotypesa
Third Generation Cephalosporins 
Resistant Isolates
blaVEB-1, %
CTX 80
CAZ 89.3
CPM 78
CRO 78.4
CTX, CAZ, CRO, CPM 97.6aAbbreviations: CTX: cefotaxime, CAZ: ceftazidime, CPM: cefpodoxime, CRO: ceftriaxone.
The prevalence of blaVEB-1 in each hospital was as fol-lows; Tehran (n = 10), Shiraz (n = 2), Ilam (n = 8), Kerman (n = 3), Kermanshah (n = 5) and Ahvaz (n = 4). Isolates that contained blaVEB-1 gene also showed higher resistance to third generation antibiotics. As described previously, several ESBL positive isolates in some hospitals did not amplify the blaVEB-1 gene. Table 4 shows the association between third-generation cephalosporins resistance and extended spectrum beta-lactamase genotypes.
5. DiscussionDrug resistance is increasingly developing amongst nosocomial pathogens (13, 14). Approximately 0.3% of P. 
aeruginosa genes encode agents for antibiotic resistance (15). The ESBL-positive P. aeruginosa strains are resistant to the extended-spectrum cephalosporins with several estimated mechanisms (16). In this study, more than 45% of the ESBL positive wound isolates contained the blaVEB-1 gene, suggesting that several other mechanisms can also interfere in decreased resistance to third generation cep-galosporins; such as reducing the levels of antibiotics ac-cumulated in bacteria or increasing the expression of ef-flux pumps that are important in gram negative strains. In the present study, the majority of the wound P. aerugi-
nosa isolates were resistant to disks of cefpodoxime and augmentin/co-amoxi clav. We observed that most of our wound isolates were sensitive to imipenem and merope-nem. Moreover, about 40% of the isolates were resistant to cefpodoxime, aztreonam, ceftriaxone and cefotaxime. The combined disk is routinely used for detection of phenotypic positive ESBLs with use a third generation cephalosporin with or without inhibitory clavulanate (17). However, resistance to the inhibitor indicates the possible presence of AmpC or other consistent enzymes (18). Several previous studies that aimed to detect ESBLs have demonstrated a high level of resistance among P. 
aeruginosa isolates to antibiotics (19). In this study, more than half of the wound ESBL positive isolates could am-plify blaVEB-1 (47%). As mentioned above, the antibiotic resistance pattern was considerably at a higher level in ESBL positive isolates (not significant). Interestingly, the 
blaVEB-1 was detected in isolates that were resistant to all 
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the used third generation cephalosporins. There are lim-ited results regarding the prevalence of the blaVEB-1 gene in Middle Eastern countries. Amongst the results from our country, 24% of ESBL positive isolates in the study of Shacheraghi et al. contained this gene (20). Further-more, in Tehran, Mirsalehian demonstrated that 49.25% and 31.34% of ESBL positive isolates collected from burn patients amplified blaPER-1 and blaVEB-1 genes, respectively (21). However, in Korea, none of the P. aeruginosa isolates could amplify the blaVEB-1 gene (10). Although we detect-ed this gene at a low prevalence, because of its plasmid borne nature, there is a possibility of rapid transmission amongst gram-negative bacteria. Fortunately, carbapen-em resistance was not high, as found by the study of Mir-salehian (21). However, another study exhibited that 95% of ESBL positive isolates of P. aeruginosa were resistant to imipenem and meropenem; such findings may be warn-ing of a crisis, as these drugs are the best choices for ESBL positive isolates. In an Iranian study, conducted in the Semnan province during 2010, 88% of gram negative iso-lates harbored ESBLs (22). However, Aminzadeh in a study conducted in Tehran during 2011, determined that 13.7% of enteric pathogens (a total of 292 species) were ESBL positive (23). Khosravi in 2012 investigated several iso-lates of Klebsiella pneumonia and found that 47.27% were ESBL positive containing TEM-1 (34.61%), SHV-1 (46.15%) and CTX-M-1 (26.92%) genes (24). In the research of Fazeli, 71% of K. pneumonia isolates were ESBL positive (25). In the study of Kapur from India, 61% of urinary tract pathogens were ESBL positive (26). For resistant isolates combina-tion therapy (usually including a class of β-lactam and an aminoglycoside) is recommended that would contribute to the curing of pseudomonal infections (27). Less than half of our wound isolates of P. aeruginosa produced ES-BLs among which an approximate half could amplify the 
blaVEB-1 gene. These isolates showed a higher drug resis-tance compared to ESBL negative strains. On the other hand, the resistance to carbapenems was low.
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